Skip to main content
. 2024 Jun 10;14(6):e064245. doi: 10.1136/bmjopen-2022-064245

Figure 1.

Figure 1

Patient disposition and study population by practice type and investigator-classified asthma severity in the SABINA III Singapore cohort. *All patients under specialist care were treated by a pulmonologist. SABA, short-acting β2-agonist; SABINA, SABA use IN Asthma.